Results 181 to 190 of about 61,637 (294)

The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications: 2. Analysis of drug trials and predictive value of the model

open access: yesEpilepsia, EarlyView.
Abstract Clinical development of novel antiseizure medications (ASMs) would benefit from an early proof of principle (POP) model. The photosensitivity model, which uses the photoparoxysmal electroencephalographic response (PPR) as a surrogate of seizures, is currently the only human model that allows POP trials of investigational compounds after a ...
Wolfgang Löscher   +1 more
wiley   +1 more source

Status epilepticus in older adults: A critical review

open access: yesEpilepsia, EarlyView.
Abstract Older adults (≥60 years of age) have the highest incidence of status epilepticus (SE) among adults and experience the highest morbidity and mortality. SE incidence increases with age in adulthood. A recent study from Austria estimated an incidence of 89.6/100 000 and 67.6/100 000 person‐years adjusted for age and sex in women and men aged >60 ...
Matthew R. Woodward   +5 more
wiley   +1 more source

The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications. 1. Use of the EEG in drug development and characteristics of the model

open access: yesEpilepsia, EarlyView.
Abstract Clinical development of novel antiseizure medications (ASMs) would benefit from an early proof‐of‐principle (POP) model. The photosensitivity model, which uses the photoparoxysmal electroencephalography (EEG) response (PPR) as a surrogate for seizures, is currently the only human model that allows POP trials of investigational compounds after ...
Dorothée Kasteleijn‐Nolst Trenité   +1 more
wiley   +1 more source

Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Background and Objectives Carbamazepine is commonly used as the first‐line treatment for trigeminal neuralgia, but therapeutic failure due to adverse effects is frequent. While various second‐line alternatives have been suggested, there is limited evidence directly comparing these options.
Albert Muñoz‐Vendrell   +5 more
wiley   +1 more source

Comparative efficacy and safety of alternatives to sodium valproate in the management of bipolar affective disorder in people of child-bearing age: a narrative review by the European Society of Clinical Pharmacy's mental health specialist interest group. [PDF]

open access: yesInt J Clin Pharm
Fitzgerald I   +12 more
europepmc   +1 more source

Recommendations for HLA‐B*15:02 and HLA‐A*31:01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions

open access: yesEpilepsia, 2014
U. Amstutz   +8 more
semanticscholar   +1 more source

Threshold‐dependent association between non‐rapid eye movement obstructive sleep apnea and interictal epileptiform discharges: A hospital study

open access: yesJournal of Sleep Research, Volume 34, Issue 3, June 2025.
Summary Obstructive sleep apnea frequently coexists with epilepsy, potentially influencing its pathophysiology. However, the effect of obstructive sleep apnea severity on interictal epileptiform discharges is not well understood. To explore this, we studied 108 Asian patients with epilepsy who underwent single‐night polysomnography.
Meina Wu   +3 more
wiley   +1 more source

Efficacy and safety of lacosamide in patients with trigeminal neuralgia: an 8-week pilot dose-escalation study. [PDF]

open access: yesJ Oral Facial Pain Headache
Lappichetpaiboon P   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy